Skip to main content
Erschienen in: Osteoporosis International 8/2019

24.05.2019 | Original Article

Increased risk of osteoporotic vertebral fracture in rheumatoid arthritis patients with new-onset cardiovascular diseases: a retrospective nationwide cohort study in Taiwan

verfasst von: W.-J. Hong, W. Chen, K.-J. Yeo, P.-H. Huang, D.-Y. Chen, J.-L. Lan

Erschienen in: Osteoporosis International | Ausgabe 8/2019

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Both cardiovascular diseases (CVD) and osteoporosis are common comorbidities in rheumatoid arthritis (RA) patients. Although accumulating evidence indicates a link between CVD and osteoporotic fracture, whether CVD contributes to osteoporotic fracture risk in RA has yet to be explored. We examined the incidence rate and risk factors of osteoporotic vertebral fracture in RA patients with new-onset CVD (RA-CVD) and evaluated the effects of medications on such fracture risk.

Methods

A retrospective study was conducted using a nationwide database from 2000 to 2010: 1267 RA-CVD and 1267 non-CVD patients were enrolled from 30,507 patients with newly diagnosed RA. The main outcome was the development of osteoporotic vertebral fracture. After being adjusted for age, gender, and comorbidities, the Cox proportional hazard model was used to identify independent factors contributing to osteoporotic vertebral fracture.

Results

The adjusted hazard ratio (aHR) of developing osteoporotic vertebral fracture was 1.47-fold greater in RA-CVD group than in non-CVD group (95% confidence interval 1.19–1.81, p < 0.001). Both the age above 40 years and female gender were significant risk factors for developing osteoporotic vertebral fracture in RA-CVD patients. Using patients not taking medication as a reference group, the aHR of osteoporotic vertebral fracture was significantly lower in those receiving statins (0.50), low-dose corticosteroids (0.57), or hydroxychloroquine (0.12).

Conclusions

The risk of osteoporotic vertebral fracture was significantly increased in RA-CVD patients, particularly women above 40 years of age, and could be reduced by statin therapy. However, the protective effect of low-dose corticosteroids or hydroxychloroquine on osteoporotic vertebral fracture risk needs further validation.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Choy EH, Panayi GS (2001) Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 344(12):907–916CrossRef Choy EH, Panayi GS (2001) Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 344(12):907–916CrossRef
3.
Zurück zum Zitat Schett G, Redlich K, Smolen J Inflammation-induced bone loss in the rheumatic diseases. In: Favus MJ (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism, 6th edn. American Society for Bone and Mineral Research, Durham, pp 310–317 Schett G, Redlich K, Smolen J Inflammation-induced bone loss in the rheumatic diseases. In: Favus MJ (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism, 6th edn. American Society for Bone and Mineral Research, Durham, pp 310–317
4.
Zurück zum Zitat Haugeberg G, Uhlig T, Falch JA, Halse JI, Kvien TK (2000) Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis. Arthritis Rheum 43(3):522–530CrossRefPubMed Haugeberg G, Uhlig T, Falch JA, Halse JI, Kvien TK (2000) Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis. Arthritis Rheum 43(3):522–530CrossRefPubMed
5.
Zurück zum Zitat Staa TP, Geusens P, Bijlsma JW, Leufkens HG, Cooper C (2006) Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis. Arthritis Rheum 54(10):3104–3112CrossRefPubMed Staa TP, Geusens P, Bijlsma JW, Leufkens HG, Cooper C (2006) Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis. Arthritis Rheum 54(10):3104–3112CrossRefPubMed
6.
Zurück zum Zitat Dougados M, Soubrier M, Antunez A, Balint P, Balsa A, Buch MH, Casado G, Detert J, el-zorkany B, Emery P, Hajjaj-Hassouni N, Harigai M, Luo SF, Kurucz R, Maciel G, Mola EM, Montecucco CM, McInnes I, Radner H, Smolen JS, Song YW, Vonkeman HE, Winthrop K, Kay J (2014) Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA). Ann Rheum Dis 73(1):62–68. https://doi.org/10.1136/annrheumdis-2013-204223 CrossRefPubMed Dougados M, Soubrier M, Antunez A, Balint P, Balsa A, Buch MH, Casado G, Detert J, el-zorkany B, Emery P, Hajjaj-Hassouni N, Harigai M, Luo SF, Kurucz R, Maciel G, Mola EM, Montecucco CM, McInnes I, Radner H, Smolen JS, Song YW, Vonkeman HE, Winthrop K, Kay J (2014) Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA). Ann Rheum Dis 73(1):62–68. https://​doi.​org/​10.​1136/​annrheumdis-2013-204223 CrossRefPubMed
7.
Zurück zum Zitat Daïen C, Tubery A, Beurai-Weber M, du Cailar G, Picot MC, Jaussent A et al (2019) Relevance and feasibility of a systemic screening of multimorbidity in patients with chronic inflammatory rheumatic diseases. Joint Bone Spine 86(1):49–54CrossRefPubMed Daïen C, Tubery A, Beurai-Weber M, du Cailar G, Picot MC, Jaussent A et al (2019) Relevance and feasibility of a systemic screening of multimorbidity in patients with chronic inflammatory rheumatic diseases. Joint Bone Spine 86(1):49–54CrossRefPubMed
8.
Zurück zum Zitat Lai SW, Liao KF, Lai HC, Tsai PY, Lin CL, Chen PC, Sung FC (2013) Risk of major osteoporotic fracture after cardiovascular disease: a population-based cohort study in Taiwan. J Epidemiol 23(2):109–114CrossRefPubMedPubMedCentral Lai SW, Liao KF, Lai HC, Tsai PY, Lin CL, Chen PC, Sung FC (2013) Risk of major osteoporotic fracture after cardiovascular disease: a population-based cohort study in Taiwan. J Epidemiol 23(2):109–114CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Makovey J, Macara M, Chen JS, Hayward CS, March L, Sambrook PN (2013) High osteoporotic fracture risk and CVD risk co-exist in post-menopausal women. Bone 52(1):120–125CrossRefPubMed Makovey J, Macara M, Chen JS, Hayward CS, March L, Sambrook PN (2013) High osteoporotic fracture risk and CVD risk co-exist in post-menopausal women. Bone 52(1):120–125CrossRefPubMed
11.
Zurück zum Zitat Chan KA, Andrade SE, Boles M, Buist DSM, Chase GA, Donahue JG, Goodman MJ, Gurwitz JH, LaCroix AZ, Platt R (2000) Inhibitors of hydroxymethylglutaryl-coenzyme a reductase and risk of fracture among older women. Lancet 355:2185–2188CrossRefPubMed Chan KA, Andrade SE, Boles M, Buist DSM, Chase GA, Donahue JG, Goodman MJ, Gurwitz JH, LaCroix AZ, Platt R (2000) Inhibitors of hydroxymethylglutaryl-coenzyme a reductase and risk of fracture among older women. Lancet 355:2185–2188CrossRefPubMed
12.
Zurück zum Zitat Mohamed MT, Abuelezz SA, Atalla SS, El Aziz LFA, Gorge SS (2017) The anti-osteoporotic and anti-atherogenic effects of alendronate and simvastatin in ovariectomized rats fed high fat diet: a comparative study of combination therapy versus monotherapy. Biomed Pharmacother 89(5):1115–1124. https://doi.org/10.1016/j.biopha.2017.02.105 Mohamed MT, Abuelezz SA, Atalla SS, El Aziz LFA, Gorge SS (2017) The anti-osteoporotic and anti-atherogenic effects of alendronate and simvastatin in ovariectomized rats fed high fat diet: a comparative study of combination therapy versus monotherapy. Biomed Pharmacother 89(5):1115–1124. https://​doi.​org/​10.​1016/​j.​biopha.​2017.​02.​105
15.
Zurück zum Zitat Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31(3):315–324CrossRef Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31(3):315–324CrossRef
16.
Zurück zum Zitat Deyo RA, Cherkin DC, Ciol MA (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45(6):613–619CrossRefPubMed Deyo RA, Cherkin DC, Ciol MA (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45(6):613–619CrossRefPubMed
17.
Zurück zum Zitat Kanis JA, McCloskey EV, Johansson H et al (2008) A reference standard for the description of osteoporosis. Bone 42:467–475CrossRefPubMed Kanis JA, McCloskey EV, Johansson H et al (2008) A reference standard for the description of osteoporosis. Bone 42:467–475CrossRefPubMed
19.
Zurück zum Zitat Xue AL, Wu SY, Jiang L, Feng AM, Guo HF, Zhao P (2017) Bone fracture risk in patients with rheumatoid arthritis: a meta-analysis. Medicine 96(36):e6983CrossRefPubMedPubMedCentral Xue AL, Wu SY, Jiang L, Feng AM, Guo HF, Zhao P (2017) Bone fracture risk in patients with rheumatoid arthritis: a meta-analysis. Medicine 96(36):e6983CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Jin S, Hsieh E, Peng L, Yu C, Wang Y, Wu C, Wang Q, Li M, Zeng X (2018) Incidence of fractures among patients with rheumatoid arthritis: a systemic review and meta-analysis. Osteoporos Int 29(3):1263–1275CrossRefPubMed Jin S, Hsieh E, Peng L, Yu C, Wang Y, Wu C, Wang Q, Li M, Zeng X (2018) Incidence of fractures among patients with rheumatoid arthritis: a systemic review and meta-analysis. Osteoporos Int 29(3):1263–1275CrossRefPubMed
21.
Zurück zum Zitat Farhat GN, Newman AB, Sutton-Tyrrell K, Matthews KA, Boudreau R, Schwartz AV, Harris T, Tylavsky F, Visser M, Cauley JA, for the Health ABC study (2007) The association of bone mineral density measures with incident cardiovascular disease in older adults. Osteoporos Int 18(7):999–1008CrossRefPubMed Farhat GN, Newman AB, Sutton-Tyrrell K, Matthews KA, Boudreau R, Schwartz AV, Harris T, Tylavsky F, Visser M, Cauley JA, for the Health ABC study (2007) The association of bone mineral density measures with incident cardiovascular disease in older adults. Osteoporos Int 18(7):999–1008CrossRefPubMed
22.
Zurück zum Zitat Barzilay JI, Buzkova P, Cauley JA, Robbins JA, Fink HA, Mukamal KJ (2018) The associations of subclinical atherosclerotic cardiovascular disease with hip fracture risk and bone mineral density in elderly adults. Osteoporos Int 29(10):2219–2230CrossRefPubMedPubMedCentral Barzilay JI, Buzkova P, Cauley JA, Robbins JA, Fink HA, Mukamal KJ (2018) The associations of subclinical atherosclerotic cardiovascular disease with hip fracture risk and bone mineral density in elderly adults. Osteoporos Int 29(10):2219–2230CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Parhami F, Morrow AD, Balucan J, Leitinger N, Watson AD, Tintut Y, Berliner JA, Demer LL (1997) Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler Thromb Vasc Biol 17(4):680–687CrossRefPubMed Parhami F, Morrow AD, Balucan J, Leitinger N, Watson AD, Tintut Y, Berliner JA, Demer LL (1997) Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler Thromb Vasc Biol 17(4):680–687CrossRefPubMed
24.
Zurück zum Zitat Bagger YZ, Tanko L, Alexandersen P, Qin G, Christiansen C, Prospective Epidemiological Risk Factors Study Group (2006) Radiographic measure of aorta calcification is a site-specific predictor of bone loss and fracture risk at the hip. J Intern Med 259(6):598–605CrossRefPubMed Bagger YZ, Tanko L, Alexandersen P, Qin G, Christiansen C, Prospective Epidemiological Risk Factors Study Group (2006) Radiographic measure of aorta calcification is a site-specific predictor of bone loss and fracture risk at the hip. J Intern Med 259(6):598–605CrossRefPubMed
25.
Zurück zum Zitat Oelzner P, Schwabe A, Lehmann G, Eidner T, Franke S, Wolf G, Hein G (2008) Significance of risk factors for osteoporosis is dependent on gender and menopause in rheumatoid arthritis. Rheumatol Int 28(11):1143–1150CrossRefPubMed Oelzner P, Schwabe A, Lehmann G, Eidner T, Franke S, Wolf G, Hein G (2008) Significance of risk factors for osteoporosis is dependent on gender and menopause in rheumatoid arthritis. Rheumatol Int 28(11):1143–1150CrossRefPubMed
27.
Zurück zum Zitat Buhaescu I, Izzedine H (2007) Mevalonate pathway: a review of clinical and therapeutic implications. Clin Biochem 40(9–10):575–584CrossRefPubMed Buhaescu I, Izzedine H (2007) Mevalonate pathway: a review of clinical and therapeutic implications. Clin Biochem 40(9–10):575–584CrossRefPubMed
29.
Zurück zum Zitat An T, Hao J, Sun S, Li R, Yang M, Cheng G, Zou M (2017) Efficacy of statins for osteoporosis: a systemic review and meta-analysis. Osteoporos Int 28:47–57CrossRefPubMed An T, Hao J, Sun S, Li R, Yang M, Cheng G, Zou M (2017) Efficacy of statins for osteoporosis: a systemic review and meta-analysis. Osteoporos Int 28:47–57CrossRefPubMed
30.
Zurück zum Zitat Redlich K, Smolen JS (2012) Inflammatory bone loss: pathogenesis and therapeutic intervention. Nat Rev Drug Discov 11:234–250CrossRefPubMed Redlich K, Smolen JS (2012) Inflammatory bone loss: pathogenesis and therapeutic intervention. Nat Rev Drug Discov 11:234–250CrossRefPubMed
31.
Zurück zum Zitat Haugeberg G, Starnd A, Kvien TK, Kirwan JR (2005) Reduced loss of bone density with prednisone in early RA, a randomized placebo-controlled trial. Arch Intern Med 165(11):1293–1297CrossRefPubMed Haugeberg G, Starnd A, Kvien TK, Kirwan JR (2005) Reduced loss of bone density with prednisone in early RA, a randomized placebo-controlled trial. Arch Intern Med 165(11):1293–1297CrossRefPubMed
32.
Zurück zum Zitat Ghazi M, Kolta S, Briot K, Fechtenbaum J, Paternotte S, Roux C (2012) Prevalence of vertebral fractures in patients with rheumatoid arthritis: revisiting the role of glucocorticoids. Osteoporos Int 23:581–587CrossRefPubMed Ghazi M, Kolta S, Briot K, Fechtenbaum J, Paternotte S, Roux C (2012) Prevalence of vertebral fractures in patients with rheumatoid arthritis: revisiting the role of glucocorticoids. Osteoporos Int 23:581–587CrossRefPubMed
33.
Zurück zum Zitat Cheng TT, Lai HM, Yu SF, Chiu WC, Hsu CY, Chen JF, Chen YC (2018) The impact of low-dose glucocorticoids on disease activity, bone mineral density, fragility fractures, and 10-year probability of fractures in patients with rheumatoid arthritis. J Investig Med 66:1004–1007CrossRefPubMedPubMedCentral Cheng TT, Lai HM, Yu SF, Chiu WC, Hsu CY, Chen JF, Chen YC (2018) The impact of low-dose glucocorticoids on disease activity, bone mineral density, fragility fractures, and 10-year probability of fractures in patients with rheumatoid arthritis. J Investig Med 66:1004–1007CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Kawai VK, Grijalva CG, Arbogast PG, Curtis JR, Solomon DH, Delzell E, Chen L, Ouellet-Hellstrom R, Herrinton L, Liu L, Mitchell EF Jr, Stein CM, Griffin MR (2013) Initiation of tumor necrosis factor α antagonists and risk of fractures with selected rheumatic and autoimmune diseases. Arthritis Care Res 65(7):1085–1094. https://doi.org/10.1002/acr.21937 CrossRef Kawai VK, Grijalva CG, Arbogast PG, Curtis JR, Solomon DH, Delzell E, Chen L, Ouellet-Hellstrom R, Herrinton L, Liu L, Mitchell EF Jr, Stein CM, Griffin MR (2013) Initiation of tumor necrosis factor α antagonists and risk of fractures with selected rheumatic and autoimmune diseases. Arthritis Care Res 65(7):1085–1094. https://​doi.​org/​10.​1002/​acr.​21937 CrossRef
39.
Zurück zum Zitat Kim SY, Schneeweiss S, Liu J, Solomon DH (2012) Effects of disease-modifying antirheumatic drugs on nonvertebral fracture risk in RA. J Bone Miner Res 27(4):789–796CrossRefPubMedPubMedCentral Kim SY, Schneeweiss S, Liu J, Solomon DH (2012) Effects of disease-modifying antirheumatic drugs on nonvertebral fracture risk in RA. J Bone Miner Res 27(4):789–796CrossRefPubMedPubMedCentral
40.
Metadaten
Titel
Increased risk of osteoporotic vertebral fracture in rheumatoid arthritis patients with new-onset cardiovascular diseases: a retrospective nationwide cohort study in Taiwan
verfasst von
W.-J. Hong
W. Chen
K.-J. Yeo
P.-H. Huang
D.-Y. Chen
J.-L. Lan
Publikationsdatum
24.05.2019
Verlag
Springer London
Erschienen in
Osteoporosis International / Ausgabe 8/2019
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-019-04966-z

Weitere Artikel der Ausgabe 8/2019

Osteoporosis International 8/2019 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.